Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
Meta Analysis Academy shared on X:
”New Meta Master Publication Alert
A systematic review and Meta-Analysis of 5 studies (n=959 patients) compared direct-acting oral anticoagulants (DOACs) vs. vitamin K antagonists (VKAs) in kidney transplant recipients (KTRs).
Key findings:
- DOACs reduced major bleeding
- DOACs lowered mortality
- No significant difference in VTE risk, in graft failure and kidney function (eGFR)
Conclusion: DOACs may be an effective anticoagulation strategy in KTRs, offering reduced bleeding and mortality compared with VKAs, though evidence quality remains low-to-moderate.”
Read the full article here.
Article: Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: A systematic review and meta-analysis
Authors: Maria Meritxell Roca Mora, Andre Milani Reis, Filipe Piazzi Tavares, Lídia Santos Oliveira, Amanda Godoi, Patricia Viana, Juliano Riella
Stay updates on the latest advances in the field of anticoagulation with Hemostasis Today.
-
Feb 1, 2026, 13:32Shiny K. Kajal: A Series On Reaching the Diagnosis of Immune Thrombocytopenia
-
Feb 1, 2026, 13:26Mary Cushman: Association of Atrial Fibrillation with Risk of Incident Cognitive Impairment
-
Feb 1, 2026, 13:23Abdulrahman Katib: Extended Low-Dose DOAC May Reduce VTE Recurrence
-
Feb 1, 2026, 13:22Jeff June: The Stroke That Wasn’t New – Why ‘Cryptogenic’ Often Means Undetected
-
Feb 1, 2026, 13:11Panagiotis Doukas: Plasma Desmosine as a Biomarker of Increased Proteolytic Activity in the Aortic Wall
-
Feb 1, 2026, 12:54Pierpaolo Di Micco: Starting a New Era for Anticoagulant Treatments
-
Feb 1, 2026, 12:16Erwin Loh: Immunotherapy Reduces Plaque in Arteries of Mice
-
Feb 1, 2026, 12:06Ney Carter Borges: The Central Role of Endothelial Dysfunction in Cardiovascular Disease Progression
-
Feb 1, 2026, 12:05Causes of Anemia – A Quick Overview From Mahnoor Shah